athira pharma stock forecast
Get the latest ATHA stock forecast powered by the most important price indicators. Forecast for 2022 Aug.
Seattle Biotech Athira Pharma Sets Terms For Ipo Aims To Raise Up To 170m Geekwire
Stock price fell by -139 on the last day Monday 24th Oct 2022 from 361 to 356.
. Athira Pharma Inc ATHA Stock Forecast By Analysts Moderate Buy Analysts Recommendations for Athira Pharma Inc ATHA is based on 10 Institutional Analyst Ratings where 4000 are. Is Athira Pharma Stock Undervalued. Athira Pharma has generated 200 earnings per share over the last year 200 diluted earnings per share.
The Athira Pharma Inc. Is 334 for 2027 Jul. BOTHELL Wash Nov.
Based on 2 Wall Street analysts offering 12 month price targets for Athira Pharma in the last 3 months. ATHA Stock Price Prediction. The forecasts range from a low of 350 to a high of 3300.
From AI system total return is 260451. ATHA stock forecast Our latest prediction for Athira Pharma Incs stock price was made on the July 6 2022 when the stock price was at 339. The average price target is 1300 with a high forecast of.
Athira Pharma stock price forecast. Get an edge in the market with our Athira Pharma Inc. Report 310 -032 Volume.
Rooms Rankings Earnings Newsletters. Real-time trade and investing ideas on Athira Pharma Inc ATHA from the largest community of traders and investors. Athira Pharma Stock Forecast.
According to 12 stock analysts the average 12-month stock price forecast for ATHA stock is 103 which predicts an increase of 19471. Athira Pharma to Present Preclinical Data Highlighting Therapeutic Potential of HGFMET Platform in Neurodegenerative Disorders at Neuroscience 2022 Conference October. The lowest target is 303 and.
1 day and price target of 330 USD. In the short term 2weeks. Analyst Price Targets 5.
ATHA a late clinical-stage biopharmaceutical company focused on developing. Athira Pharma Inc stock price forecast for further price development up to 578 time horizon. 09 2022 GLOBE NEWSWIRE -- Athira Pharma Inc.
Is 337 for 2023 Jul. The current Athira Pharma ATHA share price is 356. Stock Forecast NASDAQATHA Open Broker Account NASDAQ Stock Exchange Healthcare Biotechnology Watchlist.
The Score for ATHA is 75 which is 50 above its historic median. Find real-time ATHA - Athira Pharma Inc stock quotes company profile news and forecasts from CNN Business. The average price target represents an increase of 38936 from the last closing price of 329.
Athira Pharma Stock Forecast for 2022. Stock forecast for tomorrow and next 5 days. Earnings for Athira Pharma are expected to decrease in the.
Is 348 for 2026 Jul. According to 6 Wall Street analyst s that have issued a 1 year ATHA price target the average ATHA price target is 1600 with the highest ATHA stock price forecast at 3300 and the. During the last trading day the stock fluctuated 674 from a.
Is 407 and for 2031 Jul. Athira Pharma Inc.
What Type Of Shareholders Make Up Athira Pharma Inc S Nasdaq Atha Share Registry
Athira Pharma Inc Atha Stock Price Quote News Stock Analysis
Athena Gold Stock Forecast Down To 0 000001 Usd Atha Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis
Athira Pharma Inc Atha Stock Price Quote News Stock Analysis
Athira Pharma Seeks 160 Million To Advance Alzheimer S Treatment Nasdaq Atha Seeking Alpha
Athira Pharma Atha Charts Dma Sma Ema Technical Analysis Macd Adx Rsi Cci Indicators
Atha Stock Forecast Price Targets And Analysts Predictions Tipranks
Atha Athira Pharma Inc Stock Overview U S Nasdaq Barron S
Athira Pharma Atha Charts Dma Sma Ema Technical Analysis Macd Adx Rsi Cci Indicators
2022 Mid Year Securities Litigation Update Gibson Dunn
Athira Fails In Alzheimer S Piling On Pain Before Phase 3 Data
Atha Investor Alert Bronstein Gewirtz Grossman Llc Notifies Athira Pharma Inc Investors Of Class Action And Encourages Shareholders To Contact The Firm Oneida Dispatch
Gibson Dunn Offers 2022 Mid Year Securities Litigation Update Cls Blue Sky Blog
Athira Pharma Stock Climbs On Alzheimer S Test As Ceo Resigns Thestreet
Bothell Biotech Firm And Activist Investor Feud Over Control Of Alzheimer S Research The Seattle Times
Athira Pharma Stock Nasdaq Atha Quotes And News Summary Benzinga
Biogen S Aduhelm Win Opened Up Market Frenzy For Alzheimer S Focused Companies Fierce Biotech